| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 387,581 | 388,836 | 354,456 | 345,344 | | Cost of Revenue | 288,687 | 287,608 | 271,071 | 272,447 | | | Gross Profit | 98,894 | 101,228 | 83,385 | 72,897 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,555 | 25,797 | 23,719 | 24,266 | | Non Recurring | 4,079 | 2,912 | 3,757 | 6,633 | | Others | 15,451 | 15,197 | 14,720 | 14,124 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 54,809 | 57,322 | 41,189 | 27,874 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 132 | 293 | 198 | 270 | | Earnings Before Interest And Taxes | 54,941 | 57,615 | 41,387 | 28,144 | | Interest Expense | 74 | 186 | 73 | 75 | | Income Before Tax | 54,867 | 57,429 | 41,314 | 28,069 | | Income Tax Expense | 20,403 | 22,036 | 15,922 | 11,096 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 34,464 | 35,393 | 25,392 | 16,973 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,464 | 35,393 | 25,392 | 16,973 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,464 | $35,393 | $25,392 | $16,973 |
|
0.63% Nasdaq 
0.03%
Income Statement
